Apoptotic machinery diversity in multiple myeloma molecular subtypes

被引:19
作者
Gomez-Bougie, Patricia [1 ,2 ,3 ,4 ]
Amiot, Martine [1 ,2 ,3 ]
机构
[1] INSERM, U892, Nantes, France
[2] Univ Nantes, Nantes, France
[3] CNRS, UMR 6299, Nantes, France
[4] CHU Nantes, Serv Hematol, F-44035 Nantes 01, France
关键词
multiple myeloma; MGUS; Bcl-2; family; CCND1; MMSET; MAF;
D O I
10.3389/fimmu.2013.00467
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple myeloma (MM) is a plasma-cell (PC) malignancy that is heterogeneous in its clinical presentation and prognosis. Monoclonal gammopathy of undetermined significance (MGUS) consistently preceded development of MM. The presence of primary IgH translocations and the universal overexpression of cyclin D genes led to a molecular classification of MM patients into different disease subtypes. Since Bcl-2 family proteins determine cell fate, we analyzed a publicly available Affymetrix gene expression of 44 MGUS and 414 newly diagnosed MM patients to investigate (1) the global change of BcI-2 family members in MM versus MGUS (2) whether the four major subtypes defined as hyperdiploid, CyclinD1, MAF, and MMSET, display specific apoptotic machineries. We showed that among the main anti-apoptotic members (BcI-2, BcI-x(L), and Mcl-1), Mcl-1 up-regulation discriminated MM from MGUS, in agreement with the prominent role of Mcl-1 in PC differentiation. Surprisingly, the expression of multi-domain pro-apoptotic Bak and Bax were increased during the progression of MGUS to MM. The combined profile of BcI-2, and Mcl-1 was sufficient to distinguish MM molecular groups. While specific pro-apoptotic members expression was observed for each MM subtypes, CyclinD1 subgroup, was identified as a particular entity characterized by a low expression of BH3-only (Puma, Bik, and Bad) and multi-domain pro-apoptotic members (Bax and Bak). Our analysis supports the notion that MM heterogeneity is extended to the differential expression of the BcI-2 family content in each MM subgroup. The influence of BcI-2 family profile in the survival of the different patient groups will be further discussed to establish the potential consequences for therapeutic interventions. Finally, the use of distinct pro-survival members in the different steps of immune responses to antigen raises also the question of whether the different BcI-2 anti-apoptotic profile could reflect a different origin of MM
引用
收藏
页数:6
相关论文
共 28 条
[1]   Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants [J].
Avet-Loiseau, H ;
Garand, R ;
Lodé, L ;
Harousseau, JL ;
Bataille, R .
BLOOD, 2003, 101 (04) :1570-1571
[2]   Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM ;
Zhan, FH ;
Sawyer, J ;
Barlogie, B ;
Shaughnessy, J .
BLOOD, 2005, 106 (01) :296-303
[3]   BH3 Mimetics: Status of the Field and New Developments [J].
Billard, Christian .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (09) :1691-1700
[4]   BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma [J].
Bodet, L. ;
Menoret, E. ;
Descamps, G. ;
Pellat-Deceunynck, C. ;
Bataille, R. ;
Le Gouill, S. ;
Moreau, P. ;
Amiot, M. ;
Gomez-Bougie, P. .
BRITISH JOURNAL OF CANCER, 2010, 103 (12) :1808-1814
[5]   ABT-737 is highly effective against molecular subgroups of multiple myeloma [J].
Bodet, Linda ;
Gomez-Bougie, Patricia ;
Touzeau, Cyrille ;
Dousset, Christelle ;
Descamps, Geraldine ;
Maiga, Sophie ;
Avet-Loiseau, Herve ;
Bataille, Regis ;
Moreau, Philippe ;
Le Gouill, Steven ;
Pellat-Deceunynck, Catherine ;
Amiot, Martine .
BLOOD, 2011, 118 (14) :3901-3910
[6]   Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy [J].
Chonghaile, Triona Ni ;
Sarosiek, Kristopher A. ;
Thanh-Trang Vo ;
Ryan, Jeremy A. ;
Tammareddi, Anupama ;
Moore, Victoria Del Gaizo ;
Deng, Jing ;
Anderson, Kenneth C. ;
Richardson, Paul ;
Tai, Yu-Tzu ;
Mitsiades, Constantine S. ;
Matulonis, Ursula A. ;
Drapkin, Ronny ;
Stone, Richard ;
DeAngelo, Daniel J. ;
McConkey, David J. ;
Sallan, Stephen E. ;
Silverman, Lewis ;
Hirsch, Michelle S. ;
Carrasco, Daniel Ruben ;
Letai, Anthony .
SCIENCE, 2011, 334 (6059) :1129-1133
[7]   Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death [J].
Coultas, L ;
Bouillet, P ;
Stanley, EG ;
Brodnicki, TC ;
Adams, JM ;
Strasser, A .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (04) :1570-1581
[8]   Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells [J].
Derenne, S ;
Monia, B ;
Dean, NM ;
Taylor, JK ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 2002, 100 (01) :194-199
[9]   Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance [J].
Fernandez-Luna, Jose L. .
CELLULAR SIGNALLING, 2008, 20 (11) :1921-1926
[10]   International Myeloma Working Group molecular classification of multiple myeloma: spotlight review [J].
Fonseca, R. ;
Bergsagel, P. L. ;
Drach, J. ;
Shaughnessy, J. ;
Gutierrez, N. ;
Stewart, A. K. ;
Morgan, G. ;
Van Ness, B. ;
Chesi, M. ;
Minvielle, S. ;
Neri, A. ;
Barlogie, B. ;
Kuehl, W. M. ;
Liebisch, P. ;
Davies, F. ;
Chen-Kiang, S. ;
Durie, B. G. M. ;
Carrasco, R. ;
Sezer, Orhan ;
Reiman, Tony ;
Pilarski, Linda ;
Avet-Loiseau, H. .
LEUKEMIA, 2009, 23 (12) :2210-2221